Santen Pharmaceutical Co Ltd
TSE:4536
Santen Pharmaceutical Co Ltd
Total Liabilities & Equity
Santen Pharmaceutical Co Ltd
Total Liabilities & Equity Peer Comparison
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Santen Pharmaceutical Co Ltd
TSE:4536
|
Total Liabilities & Equity
¥435.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
6%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Total Liabilities & Equity
¥15.1T
|
CAGR 3-Years
5%
|
CAGR 5-Years
2%
|
CAGR 10-Years
13%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Total Liabilities & Equity
¥3.5T
|
CAGR 3-Years
18%
|
CAGR 5-Years
11%
|
CAGR 10-Years
6%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Total Liabilities & Equity
¥3.4T
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
5%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Total Liabilities & Equity
¥1.9T
|
CAGR 3-Years
18%
|
CAGR 5-Years
15%
|
CAGR 10-Years
10%
|
|
Astellas Pharma Inc
TSE:4503
|
Total Liabilities & Equity
¥3.6T
|
CAGR 3-Years
16%
|
CAGR 5-Years
13%
|
CAGR 10-Years
8%
|
See Also
What is Santen Pharmaceutical Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
435.7B
JPY
Based on the financial report for Mar 31, 2024, Santen Pharmaceutical Co Ltd's Total Liabilities & Equity amounts to 435.7B JPY.
What is Santen Pharmaceutical Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
6%
Over the last year, the Total Liabilities & Equity growth was 3%. The average annual Total Liabilities & Equity growth rates for Santen Pharmaceutical Co Ltd have been 2% over the past three years , 2% over the past five years , and 6% over the past ten years .